Skip to main content

Advertisement

Fig. 2 | Perioperative Medicine

Fig. 2

From: Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery

Fig. 2

Cost-effectiveness acceptability curve (all patient lifetime analysis) describing the probability that peri-operative cardiac output-guided haemodynamic therapy is cost-effective for a range of decision makers’ willingness to pay thresholds per quality-adjusted life year (QALY) gained when compared with usual peri-operative care

Back to article page